Editor’s Note: In today’s guest editorial, our friend Andy Snyder, expert trader and founder of Manward Press, goes over why the energy sector is taking off and the hidden government forces behind its rise.

If you missed out on the huge bull market in energy last year… don’t worry. There will be more opportunities to cash in this year.

And it all starts with one newly listed company that’s totally changing the game. Andy has all the details on its breakthrough technology that could dominate oil and gas production in America… and send the stock soaring as much as 740% within two years.

See how this company could transform the oil and gas industry right here.

– Ryan Fitzwater, Associate Publisher

The energy sector is hot… hot… hot.

Investors who have followed our lead are doing quite well. Chevron is buying back billions of dollars’ worth of shares. Exxon is crushing records. And the poor, poor president is wagging his finger at all the easy money.

The truth, of course, is the president and his like-minded cronies should get full credit for the sector’s profit-gushing ways. It wouldn’t have record-breaking earnings without the perverted incentives created by government policy.

The elected class put all their money on the wrong horse – a mere pony amongst great stallions.

When the race came to the backstretch, their entry couldn’t keep up.

The earnings went to the big and the experienced.

And it’s not just oil where we’re seeing this play out.

That’s what I’m begging my readers to understand. The government’s manipulations of the energy sector have disrupted things far and wide.

Be Careful

I’ve written a few words about EVs over the years. And my top pick in this red-hot sector recently soared as much as 85% in one day.

In late January, though, the bidding went to Lithium Americas (LAC). The lithium miner surged by 15% as word spread that General Motors is investing $650 million in the company.

Investors who have long touted lithium investments as the next big boom pumped their fists high into the air.

But be careful, I say.

GM’s new toy isn’t actually a lithium producer… not quite yet.

You see, the carmaker is putting its money into a specific project. It wants to help Lithium Americas develop a deposit known as Thacker Pass. But the project won’t actually produce any of the metal until late 2026.

That’s three years from now… darn near an eternity in today’s EV market.

Investors (mainly retail investors) are pricing perfection into the market. They’re expecting to see what we’ve all read about – that there’s not enough lithium to meet demand.

At almost every public event I attend, somebody pulls me aside and proudly whispers about their moves into the lithium market. Everyone seems to be convinced it’s the next big thing.

I say hold on a minute.

There are ample signs of bullishness. But there’s also plenty of reason to believe that the market is chasing its tail on this one… that it’s pushing prices higher in yet another cheap-money-induced speculative bubble.

Trouble

You see, something peculiar happened in the EV space last year.

Carmakers couldn’t build cars. Just about every manufacturer in the space got dinged because they couldn’t get the high-end processors they needed. Tesla’s shares took a big hit because of it.

This problem zapped the fundamental bullishness for the lithium sector.

What was once expected to be a 15,000-metric-ton shortage of lithium (that’s about $825 million worth of the metal at current prices) is now expected to turn into a surplus of some 2,000 metric tons this year.

That’s a huge turnaround. I expect the surplus to grow even more as time does what time does.

What’s even more interesting are the pricing forecasts from the folks in the industry. My research shows most analysts believe lithium prices peaked last year and are likely to level out over the next three years.

And let’s not forget the other market forces at play here. Battery technology is changing quickly. Lithium is expensive, and it’s very dirty to produce, store and dispose of (shh… the environmental crowd with their feel-good blinders don’t want you to know this). Manufacturers are racing to find alternatives.

With the markets pricing in tremendous growth for so many lithium stocks – not unlike what we saw with tech stocks in the late 1990s – any speed bump in the road ahead will be trouble for shareholders. Let’s not forget that GM’s latest investment has zero revenues and is losing about $100 million per year… yet has a $3.4 billion price tag. The investment from Detroit (the size of a rounding error for GM) will merely help keep the lights on.

YOUR ACTION PLAN

There are better investment opportunities in the energy sector right now…

Like this under-the-radar company with a breakthrough technology that could revolutionize the oil and gas sector. I wouldn’t be surprised if the government soon requires its tech. If that happens, this newly public stock could go ballistic.

Get all the details on the company right here… including why I believe it could jump as much as 740% over the next two years.

Click here to find out more.

Be well,

Andy

MONDAY MARKET MINUTE

• AI Trend Goes Mainstream. The artificial intelligence gold rush that we’ve been playing has now made it onto the cover of Barron’s. As a speculative play, C3.ai (AI) remains one to trade in and out of… if you’re nimble enough to buy the dips and sell the rips. Tracking.
• Hertz Getting Momentum. As Trade of the Day Plus members know, we really like Hertz at current levels. And now Barron’s has jumped onto the bullish bandwagon – saying that “it’s time to take Hertz stock out for a spin.” The company is now highly profitable as it continues to recover from bankruptcy.
• Time to Play Defense Again? Our favorite defense/aerospace play, Raytheon Technologies (RTX), is perking up – and could be ready to push up and retest $108. This could be one to take a look at this week.
• Eye Company Pops in Premarket. Ocular Therapeutix (OCUL) is up 21% after announcing interim 10-month data from its U.S. Phase 1 clinical trial evaluating OTX-TKI, the company’s axitinib intravitreal hydrogel implant being developed for the treatment of wet age-related macular degeneration, diabetic retinopathy and other retinal diseases.